In the Research Letter titled “Analysis of State-Level Drug Pricing Transparency Laws in the United States,”[1] published September 25, 2019, in the first column of the eTable in the Supplement, the first row should have been labeled “State & Bill/Rule/Statute”; row 12, “KY SB 117”; row 22, “MD 15-1628.1”; row 24, “MN 151.214”; and row 36, “VT S 92/A 193.” In the second column, row 23 should have read “2018.” This article has been corrected.[1]